0001178913-22-004054.txt : 20221115
0001178913-22-004054.hdr.sgml : 20221115
20221115161324
ACCESSION NUMBER: 0001178913-22-004054
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221111
FILED AS OF DATE: 20221115
DATE AS OF CHANGE: 20221115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yaacov-Garbeli Dana
CENTRAL INDEX KEY: 0001909822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38556
FILM NUMBER: 221391315
MAIL ADDRESS:
STREET 1: KIRYAT HADASSAH
STREET 2: MINRAV BUILDING, FIFTH FLOOR
CITY: JERUSALEM
STATE: L3
ZIP: 9112002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entera Bio Ltd.
CENTRAL INDEX KEY: 0001638097
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: KIRYAT HADASSAH, MINRAV BUILDING
STREET 2: FIFTH FLOOR
CITY: JERUSALEM
STATE: L3
ZIP: 9112002
BUSINESS PHONE: 972-2-532-7151
MAIL ADDRESS:
STREET 1: KIRYAT HADASSAH, MINRAV BUILDING
STREET 2: FIFTH FLOOR
CITY: JERUSALEM
STATE: L3
ZIP: 9112002
4
1
zk2228766.xml
X0306
4
2022-11-11
0
0001638097
Entera Bio Ltd.
ENTX
0001909822
Yaacov-Garbeli Dana
KIRYAT HADASSAH
MINRAV BUILDING, 5TH FLOOR
JERUSALEM
L3
9112002
ISRAEL
0
1
0
0
Chief Financial Officer
Ordinary Shares, par value NIS 0.0000769 per share
2022-11-11
4
P
0
30000
0.52
A
30000
I
By A2Z Counseling Ltd.
Ordinary Shares, par value NIS 0.0000769 per share
2022-11-14
4
P
0
26580
0.536
A
56580
I
By A2Z Counseling Ltd.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.50 to $0.54, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These shares are owned by A2Z Counseling Ltd. of which the Reporting Person's owns a 33.33% interest and has effective control over voting and disposition of the shares. The Reporting Person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.53 to $0.54, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Dana Yaacov-Garbeli
2022-11-15